Influence of COMT genotype and affective distractors on the processing of self-generated thought

Social Cognitive and Affective Neuroscience

Volumn 10, Issue 6, 2014, Pages 777-782

  Kilford, Emma J ^a   Dumontheil, Iroise ^a,b   Wood, Nicholas W ^c   Blakemore, Sarah Jayne ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Affective processing; Behavioural genetics; COMT; Executive function; Prefrontal cortex

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; AFFECT; ATTENTION; EXECUTIVE FUNCTION; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; SHORT TERM MEMORY; THINKING; YOUNG ADULT;

ADULT; AFFECT; ATTENTION; CATECHOL O-METHYLTRANSFERASE; EXECUTIVE FUNCTION; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, GENETIC; THINKING; YOUNG ADULT;

EID: 84930863094     PISSN: 17495016     EISSN: 17495024     Source Type: Journal    
DOI: 10.1093/scan/nsu118     Document Type: Article

References (37)

1. Bar-Haim, Y., Lamy, D., Pergamin, L., Bakermans-Kranenburg, M.J., van IJzendoorn, M.H. (2007). Threat-related attentional bias in anxious and nonanxious individuals: a metaanalytic study. Psychological Bulletin, 133(1), 1-24.
2. Barnett, J.H., Jones, P.B., Robbins, T.W., Müller, U. (2007). Effects of the catechol-Omethyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Molecular Psychiatry, 12(5), 502-9.
3. Barnett, J.H., Scoriels, L., Munafò , M.R. (2008). Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biological Psychiatry, 64(2), 137-44.
4. Braver, T.S. (2012). The variable nature of cognitive control: a dual mechanisms framework. Trends in Cognitive Science, 16(2), 106-13.
5. Braver, T.S., Gray, J.R., Burgess, G.C. (2007). Explaining the many varieties of working memory variation: dual mechanisms of cognitive control. In: Conway, A.R., Jarrold, C., Kane, M.J., Miyake, A., Towse, J.N., editors. Variation in Working Memory. New York: Oxford University Press, pp. 76-106.
6. Burgess, P.W., Dumontheil, I., Gilbert, S.J. (2007). The gateway hypothesis of rostral prefrontal cortex (area 10) function. Trends in Cognitive Sciences, 11(7), 290-8.
7. Chen, J., Lipska, B.K., Halim, N., et al. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics, 75(5), 807-21.
8. Cools, R., D'Esposito, M. (2011). Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biological Psychiatry, 69(12), e113-25.
9. Dickinson, D., Elveväg, B. (2009). Genes, cognition and brain through a COMT lens. Neuroscience, 164(1), 72-87.
10. Dumontheil, I., Jensen, S.K., Wood, N.W., Meyer, M.L., Lieberman, M.D., Blakemore, S.J. (2014). Preliminary investigation of the influence of dopamine regulating genes on social working memory. Social Neuroscience, 9(5), 437-51.
11. Dumontheil, I., Roggeman, C., Ziermans, T., et al. (2011). Influence of the COMT genotype on working memory and brain activity changes during development. Biological Psychiatry, 70(3), 222-9.
12. Egger, H.L., Pine, D.S., Nelson, E., et al. (2011). The NIMH Child Emotional Faces Picture Set (NIMH-ChEFS): a new set of children's facial emotion stimuli. International Journal of Methods in Psychiatric Research, 20(3), 145-56.
13. Frith, C.D., Frith, U. (2008). Implicit and explicit processes in social cognition. Neuron, 60(3), 503-10.
14. Gilbert, S.J., Frith, C.D., Burgess, P.W. (2005). Involvement of rostral prefrontal cortex in selection between stimulus-oriented and stimulus-independent thought. The European Journal of Neuroscience, 21(5), 1423-31.
15. Gogos, J.A., Morgan, M., Luine, V., et al. (1998). Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences of the United States of America, 95(17), 9991-6.
16. Goldman, D., Oroszi, G., Ducci, F. (2005). The genetics of addictions: uncovering the genes. Nature Reviews Genetics, 6, 521-32.
17. Goldman-Rakic, P.S. (1998). The cortical dopamine system: role in memory and cognition. Advances in Pharmacology, 42, 707-11.
18. Harrison, P.J., Tunbridge, E.M. (2008). Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology, 33(13), 3037-45.
19. Jacobs, E., D'Esposito, M. (2011). Estrogen shapes dopamine-dependent cognitive processes: implications for women's health. Journal of Neuroscience, 31(14), 5286-93.
20. Jaspar, M., Genon, S., Muto, V., et al. (2014). Modulating effect of COMT genotype on the brain regions underlying proactive control process during inhibition. Cortex, 50, 148-61.
21. Lachman, H.M., Papolos, D.F., Saito, T., Yu, Y.M., Szumlanski, C.L., Weinshilboum, R.M. (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics, 6(3), 243-50.
22. Ladouceur, C.D., Silk, J.S., Dahl, R.E., Ostapenko, L., Kronhaus, D.M., Phillips, M.L. (2009). Fearful faces influence attentional control processes in anxious youth and adults. Emotion, 9(6), 855-64.
23. Meyer-Lindenberg, A., Weinberger, D.R. (2006). Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nature Reviews Neuroscience, 7(10), 818-27.
24. Mier, D., Kirsch, P., Meyer-Lindenberg, A. (2010). Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis. Molecular Psychiatry, 15(9), 918-27.
25. Millan, M., Agid, Y., Brüne, M., et al. (2012). Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature Reviews Drug Discovery, 2, 141-68.
26. Montag, C., Jurkiewicz, M., Reuter, M. (2012). The role of the catechol-O-methyltransferase (COMT) gene in personality and related psychopathological disorders. CNS and Neurological Disorders Drug Targets, 11(3), 236-50.
27. Ochsner, K.N., Gross, J.J. (2005). The cognitive control of emotion. Trends in Cognitive Sciences, 9(5), 242-9.
28. Palmatier, M.A., Kang, A.M., Kidd, K.K. (1999). Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biological Psychiatry, 46, 557-567.
29. Pooley, E.C., Fineberg, N., Harrison, P.J. (2007). The met(158) allele of catechol-Omethyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Molecular Psychiatry, 12(6), 556-61.
30. Skuse, D. (2006). Genetic influences on the neural basis of social cognition. Philosophical Transactions of the Royal Society of London B Biological Sciences, 361(1476), 2129-41.
31. Spielberger, C.D., Gorsuch, R.L., Lushene, R., Vagg, P.R., Jacobs, G.A. (1983). Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press.
32. Tottenham, N., Tanaka, J.W., Leon, A.C., et al. (2009). The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Research, 168(3), 242-9.
33. Tunbridge, E.M., Harrison, P.J., Weinberger, D.R. (2006). Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biological Psychiatry, 60(2), 141-51.
34. Wechsler, D. (1999). Wechsler Abbreviated Scale of Intelligence (WASI). San Antonio, TX: Harcourt Assessment.
35. Williams, G.V., Goldman-Rakic, P.S. (1995). Modulation of memory fields by dopamine Dl receptors in prefrontal cortex. Nature, 376, 572-75.
36. Williams, J.M.G., Watts, F.N., MacLeod, C., Mathews, A., editors. (1997). Cognitive Psychology and Emotional Disorders (2nd edn). Chichester: Wiley.
37. Witte, A.V., Flöel, A. (2012). Effects of COMT polymorphisms on brain function and behavior in health and disease. Brain Research Bulletin, 88(5), 418-28.